Revvity rises after first-quarter profit beat

Revvity

05/05/2026 14:47

Updates

** Shares of medical equipment maker Revvity RVTY.N rise 2.4% to $88.58

** Revvity posts Q1 adj. profit per share of $1.06, beating analysts' avg. estimate of $1.02 - data compiled by LSEG

** Co cut its 2026 adjusted profit to be between $5.20 and $5.30 per share, compared with its prior view in the range of $5.35 and $5.45

** Analysts were expecting annual profit to be $5.39 per share

** Co says it has decided to sell its immunodiagnostics business in China, which accounted for about 6% of total revenue in the 2025 fiscal year

** Including session moves, stock down 10.6% YTD

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))